About the absolute need to keep active research on the efficacy of direct-acting antiviral drugs against the hepatitis C virus

被引：5
|
作者：
Pawlotsky, Jean-Michel [1 ,2 ]
机构：
[1] Univ Paris Est, Hop Henri Mondor, Dept Virol, Natl Reference Ctr Viral Hepatitis B C & D, Creteil, France
[2] INSERM, U955, Viruses Hepatol Canc Res Unit, Creteil, France
来源：
JOURNAL OF HEPATOLOGY | 2020年 / 73卷 / 04期
关键词：
D O I：
10.1016/j.jhep.2020.06.029
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：752 / 754
页数：3
相关论文
共 50 条
  • [31] Direct-Acting Antiviral Drugs for the Treatment of Chronic Hepatitis C Virus Infection: Interferon Free Is Now
    Florian, J.
    Mishra, P.
    Arya, V.
    Harrington, P.
    Connelly, S.
    Reynolds, K. S.
    Sinha, V.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2015, 98 (04) : 394 - 402
  • [32] Acute hepatitis C virus infection and direct-acting antiviral drugs: Perfect combination to eliminate the epidemic?
    Gomez-Ayerbe, Cristina
    Palacios, Rosario
    Rios, Maria J.
    Tellez, Francisco
    Sayago, Carmen
    Martin-Aspas, Andres
    Camacho, Angela
    Munoz, Leopoldo
    Santos, Jesus
    INTERNATIONAL JOURNAL OF STD & AIDS, 2021, 32 (13) : 1257 - 1260
  • [33] Efficacy and Tolerability of Direct-Acting Antiviral Agents for Hepatitis C Virus Infection in Kidney Transplant Recipients
    Suna, Nuretdin
    Etik, Digdem Ozer
    Ocal, Serkan
    Selcuk, Haldun
    Dagli, Ulku
    Hilmioglu, Fatih
    Boyacioglu, Sedat
    Haberal, Mehmet
    TRANSPLANTATION, 2018, 102 : S909 - S909
  • [34] Impact of hepatitis C virus polymorphisms on direct-acting antiviral treatment efficacy: Regulatory analyses and perspectives
    Harrington, Patrick R.
    Komatsu, Takashi E.
    Deming, Damon J.
    Donaldson, Eric F.
    O'Rear, Julian J.
    Naeger, Lisa K.
    HEPATOLOGY, 2018, 67 (06) : 2430 - 2448
  • [35] Disparity in market prices for hepatitis C virus direct-acting drugs
    Andrieux-Meyer, Isabelle
    Cohn, Jennifer
    Affonso de Araujo, Evaldo S.
    Hamid, Saeed S.
    LANCET GLOBAL HEALTH, 2015, 3 (11): : E676 - E677
  • [36] Similar effectiveness of direct-acting antiviral against hepatitis C virus in patients with and without HIV infection
    Luisa Montes, Maria
    Olveira, Antonio
    Ahumada, Adriana
    Aldamiz, Teresa
    Garcia-Samaniego, Javier
    Clemente, Ana
    Berenguer, Juan
    Gonzalez-Garcia, Juan
    Martin-Carbonero, Luz
    AIDS, 2017, 31 (09) : 1253 - 1260
  • [37] Hepatitis C virus eradication with direct-acting antiviral improves insulin resistance
    Russo, Francesco Paolo
    Zanetto, Alberto
    Gambato, Martina
    Bortoluzzi, Ilaria
    Al Zoairy, Ramona
    Franceschet, Enrica
    De Marchi, Federica
    Marzi, Luca
    Lynch, Erica Nicola
    Floreani, Annarosa
    Farinati, Fabio
    Schaefer, Benedikt
    Burra, Patrizia
    Zoller, Heinz
    Mega, Andrea
    JOURNAL OF VIRAL HEPATITIS, 2020, 27 (02) : 188 - 194
  • [38] Resistance Mechanisms in Hepatitis C Virus: implications for Direct-Acting Antiviral Use
    Bagaglio, Sabrina
    Uberti-Foppa, Caterina
    Morsica, Giulia
    DRUGS, 2017, 77 (10) : 1043 - 1055
  • [39] Direct-acting antiviral hepatitis C virus treatment perturbation of the metabolic milieu
    Driedger, Matt
    Galanakis, Chrissi
    Doyle, Mary-Anne
    Cooper, Curtis L.
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2019, 31 (02) : 260 - 266
  • [40] Resistance Mechanisms in Hepatitis C Virus: implications for Direct-Acting Antiviral Use
    Sabrina Bagaglio
    Caterina Uberti-Foppa
    Giulia Morsica
    Drugs, 2017, 77 : 1043 - 1055
12345